Dendritic cell based genetic immunization stimulates potent tumor protection dependent on CD8 CTL cells in the absence of autoimmunity

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 9, 2008, Pages 987-994

  Zhang, Sheng ^a   Huang, Weiyi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Adenovirus; Autoimmune vitiligo; CD8 CTL; Dendritic cells; TRP 1

Indexed keywords

ADENOVIRUS VECTOR; ADENOVIRUS VECTOR TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 1;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CANCER CONTROL; CANCER IMMUNIZATION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENETIC IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; AUTOIMMUNITY; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; NEOPLASMS, EXPERIMENTAL; OXIDOREDUCTASES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 49649109383     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0368-4     Document Type: Article

References (29)

1. WB Bowne R Srinivasan JD Wolchok WG Hawkins NE Blachere R Dyall JJ Lewis AN Houghton 1999 Coupling and uncoupling of tumor immunity and autoimmunity J Exp Med 190 1717 1722
2. JL Bramson YH Wan 2002 The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen Expert Opin Biol Ther 2 75 85
3. + T cells requires CD154 expression by Th cells in acute graft versus host disease J Immunol 162 4373 4376
4. RA Clynes TL Towers LG Presta JV Ravetch 2000 Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets Nat Med 6 443 446
5. + T lymphocytes Cancer Res 64 8068 8076
6. JA Guevara-Patino ME Engelhorn MJ Turk C Liu F Duan G Rizzuto AD Cohen T Merghoub JD Wolchok AN Houghton 2006 Optimization of a self antigen for presentation of multiple epitopes in cancer immunity J Clin Invest 116 1382 1390
7. + cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12 Immunology 115 451 461
8. + T-cell helper epitope Cancer Res 67 6459 6467
9. C Lane J Leitch X Tan J Hadjati JL Bramson Y Wan 2004 Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin Cancer Res 64 1509 1514
10. J Leitch K Fraser C Lane K Putzu GJ Adema QJ Zhang WA Jefferies JL Bramson Y Wan 2004 CTL-dependent and -independent antitumor immunity is determined by the tumor not the vaccine J Immunol 172 5200 5205
11. B Ludewig AF Ochsenbein B Odermatt D Paulin H Hengartner RM Zinkernagel 2000 Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease J Exp Med 191 795 804
12. J Ma WJ Urba L Si Y Wang BA Fox HM Hu 2003 Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution Eur J Immunol 33 2123 2132
13. JI Malowany S McCormick M Santosuosso X Zhang N Aoki P Ngai J Wang J Leitch J Bramson Y Wan Z Xing 2006 Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts Mol Ther 13 766 775
14. SL Meijer A Dols SM Jensen HM Hu W Miller E Walker P Romero BA Fox WJ Urba 1997 Induction of circulating tumor-reactive CD8 T cells after vaccination of melanoma patients with the gp100 209-2M peptide J Immunother 30 2007 533 543
15. N Muhanna A Horani S Doron R Safadi 2007 Lymphocyte-hepatic stellate cell proximity suggests a direct interaction Clin Exp Immunol 148 338 347
16. T Ramirez-Montagut MJ Turk JD Wolchok JA Guevara-Patino AN Houghton 2003 Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity Oncogene 22 3180 3187
17. SA Rosenberg Y Zhai JC Yang DJ Schwartzentruber P Hwu FM Marincola SL Topalian NP Restifo CA Seipp JH Einhorn B Roberts DE White 1998 Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens 3 J Natl Cancer Inst 90 1894 1900
18. + T cell immunity Nat Immunol 5 1143 1148
19. + T cells and local inflammation: implications for the pathophysiology of vitiligo J Invest Dermatol 124 144 150
20. J Steitz D Tormo D Schweichel T Tuting 2006 Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination Cancer Gene Ther 13 318 325
21. J Trcka Y Moroi RA Clynes SM Goldberg A Bergtold MA Perales M Ma CR Ferrone MC Carroll JV Ravetch AN Houghton 2002 Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo Immunity 16 861 868
22. H Uchi R Stan MJ Turk ME Engelhorn GA Rizzuto SM Goldberg JD Wolchok AN Houghton 2006 Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo Adv Immunol 90 215 241
23. Y Wan J Bramson A Pilon Q Zhu J Gauldie 2000 Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines Cancer Res 60 3247 3253
24. Y Wan L Lu JL Bramson S Baral Q Zhu A Pilon K Dayball 2001 Dendritic cell-derived IL-12 is not required for the generation of cytotoxic, IFN-gamma-secreting, CD8 (+) CTL in vivo J Immunol 167 5027 5033
25. LW Weber WB Bowne JD Wolchok R Srinivasan J Qin Y Moroi R Clynes P Song JJ Lewis AN Houghton 1998 Tumor immunity and autoimmunity induced by immunization with homologous DNA J Clin Invest 102 1258 1264
26. C Wiethe M Schiemann D Busch L Haeberle M Kopf G Schuler MB Lutz 2007 Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity J Immunol 178 4908 4916
27. + T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity J Immunol 176 200 210
28. + T-cell response elicited by recombinant adenovirus vaccines Mol Ther 15 997 1006
29. S Zhang Q Wang WF Li HY Wang HJ Zhang 2004 Enhanced antitumor immunity by murine cytokine activated T lymphocytes after cocultured with bone marrow derived dendritic cells pulsed with whole tumor lysates Leuk Res 28 1085 1088